These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2939951)

  • 1. Left ventricular hypertrophy as a risk factor.
    Frohlich ED
    Cardiol Clin; 1986 Feb; 4(1):137-44. PubMed ID: 2939951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension.
    Messerli FH; Schmieder R
    Drugs; 1986; 31 Suppl 4():192-201. PubMed ID: 2942387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic considerations in left ventricular hypertrophy.
    Frohlich ED
    Am J Med; 1983 Sep; 75(3A):12-8. PubMed ID: 6226189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy: its prime importance as a controllable risk factor.
    Weber JR
    Am Heart J; 1988 Jul; 116(1 Pt 2):272-9. PubMed ID: 2969187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart effect of arterial hypertension. Heart hypertrophy as a risk factor. Study technics (electrocardiogram, echocardiography, exercise test and Holter].
    Aguilera Saldaña MA; García Moreno LM; Rodríguez Padial L; Navarro Lima A; Sánchez Domínguez J
    Rev Esp Cardiol; 1990; 43 Suppl 1():54-64. PubMed ID: 2139976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mechanisms explaining the risk of left ventricular hypertrophy.
    Frohlich ED
    Am J Cardiol; 1987 Jan; 59(2):91A-97A. PubMed ID: 2949582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Messerli FH; Soria F
    Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 11. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.
    Casale PN; Devereux RB; Milner M; Zullo G; Harshfield GA; Pickering TG; Laragh JH
    Ann Intern Med; 1986 Aug; 105(2):173-8. PubMed ID: 2942070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography.
    Cohen A; Hagan AD; Watkins J; Mitas J; Schvartzman M; Mazzoleni A; Cohen IM; Warren SE; Vieweg WV
    Am J Cardiol; 1981 Feb; 47(2):335-41. PubMed ID: 6110331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical determinants and consequences of left ventricular hypertrophy.
    Messerli FH
    Am J Med; 1983 Sep; 75(3A):51-6. PubMed ID: 6226196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy. Significance in cardiac morbidity and mortality.
    Aronow WS
    Postgrad Med; 1990 Mar; 87(4):147-50, 155-8. PubMed ID: 2138288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
    Frohlich ED
    Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of drugs for systemic hypertension and their effect on the heart.
    Cohn JN
    Am J Cardiol; 1987 Oct; 60(12):72G-74G. PubMed ID: 2960228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.